Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics
Proceeds to fund global Phase 3 registration program for the company’s lead product candidate, Obexelimab, and suppo…
Continue ReadingDay: November 9, 2022
Over Fifty Leading Chief Executives from Africa take Climate Action at COP27
Over 50 leaders from Africa’s private sector came together at COP27 and with a unified voice, called for acceler
…Continue ReadingZenas BioPharma ได้รับเงิน 118 ล้านดอลลาร์เพื่อพัฒนาแนวทางการรักษาโรคภูมิต้านตนเองในไปป์ไลน์เป็นวงกว้าง
โดยทางบริษัทได้ดำเนินการให้ทุ
Citeline and EMIS Partner to Expand Clinical Trial Access in the UK
New alliance will boost access to clinical trials for thousands of individuals in the UK through their clinicians
NE…
Continue ReadingTIS Launches FX Payment Service Across 175+ Countries With 140+ Currency Options
Offering Significantly Reduces Cross-Border Payment Costs for Global Organizations
Featured Image for TIS
Feature
Tropical Storm Nicole Bears Down on Bahamas, Florida
Many people evacuated from vulnerable locations in the northwestern Bahamas as Tropical Storm Nicole approac…
Continue ReadingJustices Seem to Favor Most of Native Child Welfare Law
The U.S. Supreme Court appeared likely Wednesday to leave in place most of a federal law that gives preference to Native …
Continue ReadingBright Peak Presents New Therapeutics Highlighted by Multifunctional PD-1 Targeted Immunocytokines at SITC 2022
– BPT567, a first-in-class PD1-IL18 immunocytokine, delivers coordinated PD-1 blockade and potent IL-18 signaling